Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Submucosal Cryotherapy and Anti-inflammatory Drugs for Postoperative Pain in Irreversible Pulpitis
NCT07919938Phase 3Not yet recruiting
- Sponsor
- Suez Canal University
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Phase 3, randomised trial of diclofenac and dexamethasone sodium phosphate in pulpitis (6 arms), sponsored by Suez Canal University. Primary endpoint: Postoperative Pain Intensity Assessed Using the Numeric Rating Scale (NRS) at 72 hours. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
diclofenacdexamethasone sodium phosphate
03
Conditions
pulpitis
Beyond the preview
Go deeper on NCT07919938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07919938.